Su-fang Y. Shi

Key Laboratory Of Renal Disease
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Clinical application of deep learning-based measurement of glomerular morphometry in IgAN.

Clinical application of deep learning-based measurement of glomerular morphometry in IgAN.

Journal: Frontiers in immunology

Published: June 16, 2026

Time-Updated Hematuria and Kidney Disease Progression in IgAN.

Time-Updated Hematuria and Kidney Disease Progression in IgAN.

Journal: Kidney international reports

Published: March 16, 2026

Construction of evidence graph of modifiable risk factors for diabetic nephropathy

Construction of evidence graph of modifiable risk factors for diabetic nephropathy

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: December 24, 2025

Re-understanding of the concept and application value of target trial emulation research

Re-understanding of the concept and application value of target trial emulation research

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: December 22, 2025

Immunoprofiling by CyTOF Uncovers Disease-Defining Peripheral Immune Signatures and Mechanistic Links to Renal Injury in IgA Nephropathy.

Immunoprofiling by CyTOF Uncovers Disease-Defining Peripheral Immune Signatures and Mechanistic Links to Renal Injury in IgA Nephropathy.

Journal: Kidney diseases (Basel, Switzerland)

Published: November 18, 2025

Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Journal: Journal of the American Society of Nephrology : JASN

Published: July 26, 2025

Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization.

Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization.

Journal: Renal failure

Published: April 15, 2025

Effectiveness of Semaglutide in Overweight or Obese Patients With IgA Nephropathy Without Diabetes.

Effectiveness of Semaglutide in Overweight or Obese Patients With IgA Nephropathy Without Diabetes.

Journal: Nephrology (Carlton, Vic.)

Published: November 20, 2024

Red blood cell casts on kidney biopsy and progression of IgA nephropathy.

Red blood cell casts on kidney biopsy and progression of IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: October 23, 2024

Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy.

Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy.

Journal: Journal of nephrology

Published: September 05, 2024

Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions(2): to improve the extrapolation of efficacy

Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions(2): to improve the extrapolation of efficacy

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: April 28, 2024

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis.

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis.

Journal: International immunopharmacology

Published: March 04, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026